Results 31 to 40 of about 105,598 (267)

Novel modulators of poly(ADP-ribose) polymerase [PDF]

open access: yesTrends in Pharmacological Sciences, 2006
The nuclear enzyme poly(ADP-ribose) polymerase (PARP)-1 has an important role in regulating cell death and cellular responses to DNA repair. Pharmacological inhibitors of PARP have entered clinical testing as cytoprotective agents in cardiovascular diseases and as adjunct antitumor therapeutics.
Csaba, Szabo   +2 more
openaire   +2 more sources

PARP-1 regulates DNA repair factor availability. [PDF]

open access: yes, 2018
PARP-1 holds major functions on chromatin, DNA damage repair and transcriptional regulation, both of which are relevant in the context of cancer. Here, unbiased transcriptional profiling revealed the downstream transcriptional profile of PARP-1 enzymatic
Birbe, Ruth   +31 more
core   +2 more sources

Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress

open access: yesRedox Biology, 2014
Oxidative stress can cause DNA breaks which induce activation of the DNA nick sensor enzyme poly(ADP-ribose) polymerase-1 (PARP-1), part of the 17 member PARP enzyme family.
Csaba Hegedűs, László Virág
doaj   +1 more source

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer

open access: yesBMC Cancer, 2020
Background Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer.
Kyung Jin Eoh   +6 more
doaj   +1 more source

Pyridazine Based Compounds with PARP-1 Inhibitory Activity

open access: yesArchives of Pharmaceutical Sciences Ain Shams University, 2023
Pyridazine-containing compounds have been identified as potent PARP1 inhibitors. The PARP is a family of enzymes essential for many cellular processes such as DNA repair, genomic stability, and apoptosis, also known as poly(ADP-ribose) synthetases and ...
Norhan A. Abdelrahman   +3 more
doaj   +1 more source

Poly(ADP‐Ribose) Polymerase in Plant Nuclei [PDF]

open access: yesEuropean Journal of Biochemistry, 1994
We show that poly(ADP‐ribose) polymerase is present in maize, pea and wheat nuclei. We have identified the enzyme product as poly(ADP‐ribose) by purification and electrophoresis on a DNA sequencing gel. This reveals a polymer ladder consisting of up to 45 residues. The polymer product from maize, after digestion with snake venom phosphodiesterase, gave
Y M, Chen, S, Shall, M, O'Farrell
openaire   +2 more sources

Poly(ADP) ribose polymerase promotes DNA polymerase theta-mediated end joining by activation of end resection

open access: yesNature Communications, 2022
Poly(ADP) ribose polymerase (PARP) activity promotes, but is not required for, chromosome break repair by polymerase theta-mediated end joining (TMEJ). PARP activity promotes TMEJ by stimulating resection, a process that controls pathway choice.
Megan E. Luedeman   +5 more
doaj   +1 more source

Kynurenine–PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension

open access: yesAnatolian Journal of Cardiology, 2022
Background: Dysregulation of microRNAs is associated with pulmonary hypertension. The present study aimed to determine the alterations in microRNA and microRNA expressions and their role in signaling pathways and investigate the relationship with serum ...
Alperen Emre Akgun   +4 more
doaj   +1 more source

PARP1 (poly(ADP-ribose) polymerase 1) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2020
PARP1 (poly(ADP-ribose) polymerase 1) is a nuclear protein involved in the regulation of various biological processes including apoptosis, DNA repair for the maintenance of genome integrity, epigenetic marking of chromatin, assembly of higher-order chromatin structures, transcriptional activation, differentiation, proliferation, and cell cycle ...
Tunçer, Sinem, Kavak, Kubra
openaire   +4 more sources

Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response

open access: yesGenome Medicine, 2018
Editorial summary Inhibitors of poly(ADP-ribose) polymerase (PARPi) have entered the clinic for the treatment of patients with cancers that lack homology-directed DNA repair, but drug resistance remains a clinical hurdle.
Paola Francica, Sven Rottenberg
doaj   +1 more source

Home - About - Disclaimer - Privacy